• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠尾动脉在α肾上腺素能受体激动剂、拮抗剂及钙拮抗剂研究中的应用

[Application of mouse tail artery for the study of alpha adrenoceptor agonists and antagonists and calcium antagonists].

作者信息

Shi C Z, Li X M, Liu Y, Zhang J T

机构信息

Institute of Materia Me lica, Chinese Academy of Medical Sciences, Beijing.

出版信息

Yao Xue Xue Bao. 1990;25(3):223-6.

PMID:1978462
Abstract

Isolated mouse tail artery strip was used for the study of alpha 1-, alpha 2-adrenoceptor agonists and antagonists. NA (alpha 1 and alpha 2 agonist) was shown to have greater activity in contracting tail artery. Phenylephrine (alpha 1 agonist) and clonidine (alpha 2 agonist) exhibited the same contractile action but much weaker than NA. Prazosin (alpha 1 antagonist) and yohimbine (alpha 2 antagonist) greatly diminished the contraction induced by phenylephrine and clonidine. These results indicate that mouse tail artery is rich in postsynaptic alpha 1- and alpha 2-adrenoceptor. In addition, mouse tail artery preparation was shown to be a useful tool for screening calcium agonists and antagonists. This model has advantages of being simple and easy to prepare, short equilibrium time and more economic in comparison with the helical strips of isolated rat tail artery.

摘要

分离的小鼠尾动脉条用于研究α1、α2肾上腺素能受体激动剂和拮抗剂。去甲肾上腺素(α1和α2激动剂)在收缩尾动脉方面表现出更强的活性。去氧肾上腺素(α1激动剂)和可乐定(α2激动剂)表现出相同的收缩作用,但比去甲肾上腺素弱得多。哌唑嗪(α1拮抗剂)和育亨宾(α2拮抗剂)极大地减弱了去氧肾上腺素和可乐定诱导的收缩。这些结果表明,小鼠尾动脉富含突触后α1和α2肾上腺素能受体。此外,小鼠尾动脉标本被证明是筛选钙激动剂和拮抗剂的有用工具。与分离的大鼠尾动脉螺旋条相比,该模型具有制备简单、平衡时间短和更经济的优点。

相似文献

1
[Application of mouse tail artery for the study of alpha adrenoceptor agonists and antagonists and calcium antagonists].小鼠尾动脉在α肾上腺素能受体激动剂、拮抗剂及钙拮抗剂研究中的应用
Yao Xue Xue Bao. 1990;25(3):223-6.
2
Contribution of alpha-adrenoceptors to depolarization and contraction evoked by continuous asynchronous sympathetic nerve activity in rat tail artery.α-肾上腺素能受体对大鼠尾动脉持续异步交感神经活动诱发的去极化和收缩的作用。
Br J Pharmacol. 1997 Apr;120(8):1513-21. doi: 10.1038/sj.bjp.0701055.
3
Postsynaptic alpha-adrenoceptor characterization and Ca2+ channel antagonist and activator actions in rat tail arteries from normotensive and hypertensive animals.正常血压和高血压动物大鼠尾动脉中突触后α-肾上腺素能受体的特征以及钙通道拮抗剂和激活剂的作用
Can J Physiol Pharmacol. 1986 Jul;64(7):909-21. doi: 10.1139/y86-157.
4
Characterization of postsynaptic alpha-adrenoceptors in the isolated rat tail artery.大鼠离体尾动脉突触后α-肾上腺素能受体的特性研究
Arch Int Pharmacodyn Ther. 1991 Jan-Feb;309:137-46.
5
Alpha-1 adrenoceptors and calcium in isolated canine coronary arteries.α1肾上腺素能受体与离体犬冠状动脉中的钙
J Pharmacol Exp Ther. 1983 Sep;226(3):668-72.
6
Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil.地尔硫䓬和维拉帕米对血管平滑肌对α1-和α2-肾上腺素能受体激动剂反应的差异性抑制作用。
Circ Res. 1983 Feb;52(2 Pt 2):I69-76.
7
Inhibition of alpha1-adrenoceptor-mediated contractions in isolated tail arteries and aorta of the rat by alpha2-adrenoceptor agonists.α2肾上腺素能激动剂对大鼠离体尾动脉和主动脉中α1肾上腺素能受体介导的收缩的抑制作用。
Res Commun Mol Pathol Pharmacol. 1995 Dec;90(3):307-20.
8
Studies that question the existence of alpha-2 adrenoceptors in tail arteries of normotensive Sprague-Dawley rats.
J Pharmacol Exp Ther. 1986 Jul;238(1):267-72.
9
Pharmacological characterization of an alpha 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat.大鼠离体尾动脉中介导去甲肾上腺素收缩反应的α1A-肾上腺素能受体的药理学特性
Br J Pharmacol. 1997 Mar;120(5):819-26. doi: 10.1038/sj.bjp.0700983.
10
Nifedipine and alpha adrenoceptors in rat aorta. II. Role of extracellular calcium in enhanced alpha-2 adrenoceptor-mediated contraction in diabetes.硝苯地平与大鼠主动脉中的α肾上腺素能受体。II. 细胞外钙在糖尿病中增强的α-2肾上腺素能受体介导的收缩中的作用。
J Pharmacol Exp Ther. 1984 Dec;231(3):603-9.